Immunogen, Inc. (IMGN) Tops Q4 EPS by 1c; Guides FY13 Loss
Tweet Send to a FriendGet Alerts IMGN Hot Sheet
Price: $15.96 -2.56%
Revenue Growth %: +669.2%
Financial Fact:
Loss from operations: -1.31M
Today's EPS Names:
CEDU, CHC, CIDM, More
Revenue Growth %: +669.2%
Financial Fact:
Loss from operations: -1.31M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade IMGN Now!
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.95 million versus the consensus estimate of $3.26 million.
Sees FY13 loss of $70 million to $74 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY13 loss of $70 million to $74 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
- Micron Technology, Inc. (MU) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
